Genetic study of complex heart defects in unborn babies
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at the genetic material in the fluid around the baby (amniotic fluid) and in the placenta to better understand complex heart defects in unborn babies. The goal is to find new clues that could help doctors care for these babies before and after birth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and pregnant.
- You are carrying a single baby (not twins or more).
- The baby has a complex heart defect that is not linked to a known genetic syndrome or infection.
- Your doctor has recommended an amniocentesis and you have agreed to it.
- Your pregnancy is between 20 and 28 weeks along.
- You understand French and are able to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to find genetic causes of congenital heart disease (a heart problem found before birth) using samples from amniocentesis or chorionic villus sampling. It may help parents get a clearer diagnosis and plan for their baby's care.
This study looks at how to improve care for babies with serious heart defects, both before and after birth. It brings together pregnancy and newborn care to help identify and treat these heart problems as early as possible.
This study follows pregnant women who have congenital heart disease (a heart problem present from birth). The goal is to monitor how both mother and baby are doing, which can help improve care for others in the same situation.
This study looks at how a mother's mental health during pregnancy may affect the brain development of babies with a serious heart condition called critical cyanotic congenital heart disease (CHD). It aims to understand this link to improve support for families.
This study looks for rare genetic changes that might explain birth defects when standard tests have not found a cause. It could help families understand why a baby has a structural problem and may guide future care.
This study uses advanced genetic testing (whole genome sequencing) on tissue samples from fetuses with structural abnormalities detected on ultrasound. The goal is to identify genetic causes of birth defects to help with diagnosis and understanding of your baby's condition.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.